ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN THE OUTPATIENT SETTING: A SINGLE CENTER EXPERIENCE OF 924 CONSECUTIVE TRANSPLANTS

EHA Library, Salwa Saadeh, 215886

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

EHA Library, Stine Ulrik Mikkelsen, 215880

PATIENTS WITH LOW JAK2 ALLELE BURDEN HAVE A HIGH RATE OF CO-OCCURRENT CALR MUTATIONS BEARING AN EFFECT ON DISEASE PHENOTYPE IN ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS.

EHA Library, Barbara Mora, 215878

PROGNOSTIC SIGNIFICANCE OF MAGNETIC RESONANCE IMAGING BEFORE AND AFTER UPFRONT AUTOLOGOUS TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA – A SUBGROUP ANALYSIS FROM THE GMMG MM5 PHASE III TRIAL

EHA Library, Maximilian Merz, 215873

PEPTIDE STIMULATION OF PD-L1 SPECIFIC T CELLS NATURALLY OCCURING IN MYELOMA PATIENTS AUGMENT THE ADCC ACTIVITY OF DARATUMUMAB

EHA Library, Nicolai Jørgensen, 215870

ADAR1-MEDIATED-A-TO-I-EDITING IS BIOLOGICALLY AND CLINICALLY RELEVANT IN MULTIPLE MYELOMA

EHA Library, Phaik Ju Teoh, 215869

EXPRESSION OF P53 ISOFORMS AT MRNA LEVEL IN MULTIPLE MYELOMA: IMPLICATIONS FOR CLINICAL OUTCOME

EHA Library, Elizabeta A. Rojas, 215868

A HIGH PRE-TREATMENT BONE MARROW CD34+/CD38- CELL BURDEN IN PATIENTS WITH MYELODYSPLASTIC SYNDROME IS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Madlen Jentzsch, 215887

ANTICOAGULATION IN THE OBESE - A PROSPECTIVE REGISTRY

EHA Library, Georgia McCaughan, 215888

TISSUE PLASMINOGEN ACTIVATOR GENE POLYMORPHISM AND RECURRENCE OF VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS FROM THE NORTH-WEST REGION OF RUSSIA

EHA Library, Anna Chechulova, 215889

DETERMINANTS AND CLINICAL SIGNIFICANCE OF MUSCULOSKELETAL SYMPTOMS IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Ana Zelic Kerep, 215885

A QUALITATIVE ANALYSIS OF PSYCHOLOGICAL HEALTH MEASURES IN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA AFTER BEING TREATED WITH BFM-ALL PROTOCOLS

EHA Library, Asif Iqbal, 215884

NOVEL KINASE INHIBITORS AFURESERTIB AND PIM447 ARE ACTIVE IN A PREDICTIVE MYELOMA IN VIVO MODEL, AND A CRISPR GENOME-WIDE SCREENING APPROACH IDENTIFIES BIOMARKERS DETERMINING SUSCEPTIBILITY

EHA Library, Niamh Keane, 215871

GENOMIC CHARACTERIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MULTIPLE MYELOMA REVEALS DISTINCT PATTERNS OF DISEASE EVOLUTION

EHA Library, Aino-Maija Leppä, 215872

ANTI-SLAMF7 ANTIBODY SUPPRESSES FIBROCYTE DIFFERENTIATION AS A POTENT THERAPEUTIC AGENT FOR MYELOFIBROSIS

EHA Library, Takaaki Maekawa, 215874

HETEROZYGOUS CONSTITUTIVE CALR DEL52 KNOCK-IN MICE SHOW A TRANSPLANTABLE ET-PHENOTYPE WHILE THE HOMOZYGOUS STATE IS LETHAL DUE TO A HEART DEFECT

EHA Library, Thomas Balligand, 215875

PATIENT-DERIVED INDUCED PLURIPOTENT STEM CELLS REVEALED CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE 2 AS A POTENTIAL THERAPEUTIC TARGET OF MYELOFIBROSIS

EHA Library, Masashi Miyauchi, 215876

DEVELOPMENT OF A PROGNOSTICALLY RELEVANT ‘CACHEXIA INDEX’ IN PRIMARY MYELOFIBROSIS USING SERUM ALBUMIN AND CHOLESTEROL LEVELS

EHA Library, maura nicolosi, 215877

MUTATIONAL LANDSCAPE AND ITS IMPACT ON OUTCOMES IN ACCELERATED AND BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Caroline Mcnamara, 215879

MYC-MEDIATED DOWNREGULATION OF MIR-150 CONTRIBUTES TO THE TRANSFORMATION OF FOLLICULAR LYMPHOMA BY UPREGULATING FOXP1 LEVELS

EHA Library, Jan Devan, 215881

PREEMPTIVE RITUXIMAB HAS A FAVORABLE BENEFIT-RISK BALANCE IN THE PREVENTION OF LONG-TERM RELAPSES IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Matthieu Jestin, 215882

SHORT- AND LONG-TERM ELTROMBOPAG FOR THE TREATMENT OF INHERITED THROMBOCYTOPENIAS: A PHASE 2 CLINICAL TRIAL

EHA Library, Carlo Zaninetti, 215883

RELEVANCE: PHASE III EFFICACY AND SAFETY STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY, FOLLOWED BY RITUXIMAB, IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Franck Morschhauser, 215924

MPN CALR MUTANTS PROMOTE CELL-SURFACE LOCALIZATION OF TPOR WHICH IS OBLIGATORY FOR ONCOGENESIS: NOVEL THERAPEUTIC AVENUES AND RESCUE OF CONGENITAL THROMBOCYTOPENIA TPOR MUTANTS

EHA Library, Christian Pecquet, 215926

CHRONIC RED BLOOD CELL TRANSFUSIONS IMPAIR THE INNATE IMMUNE RESPONSE TO INFECTIOUS CUES BY SHAPING MACROPHAGES TOWARDS AN ANTI-INFLAMMATORY FUNCTIONAL PHENOTYPE.

EHA Library, Francesca Vinchi, 215928

Test

EHA Library, Romain Froger, 219400

OVERALL SURVIVAL BENEFIT OF OBINUTUZUMAB OVER RITUXIMAB WHEN COMBINED WITH CHLORAMBUCIL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND COMORBIDITIES: FINAL SURVIVAL ANALYSIS OF THE CLL11 STUDY

EHA Library, Valentin Goede, 215923

RIBOSOMAL LESIONS PROMOTE ONCOGENIC MUTAGENESIS

EHA Library, Sergey Sulima, 215927

FIRST-IN-HUMAN CLL1-CD33 COMPOUND CAR T CELLS AS A TWO-PRONGED APPROACH FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Fang Liu, 215925

How to test and transfuse blood products in sub-Saharan Africa

EHA Library, Jean Pierre Allain, 219129

Inhibitors of isocitrate dehydrogenase in the treatment of acute myeloid leukemia

EHA Library, Eytan Stein, 219126

Resolving hematopoiesis by fate mapping and polylox barcoding

EHA Library, Hans-Reimer Rodewald, 219122

Perspectives with CAR-T for resistant ALL and beyond

EHA Library, Sara Ghorashian, 219119

Designing clinical scale production of iPSC-derived platelets by a novel flow concept

EHA Library, Koji Eto, 219123

Blood transfusion in developing countries: The case of Malawi and other African countries

EHA Library, Brindon M'baya, 219128

Epigenetic inhibitors in hematological malignancies

EHA Library, Brian Huntly, 219125

David Grimwade Award Lecture: Precision medicine for blood cancers through knowledge banks

EHA Library, Peter Campbell, 219116

Award ceremony: Presentation Young EHA Best abstracts

EHA Library, Martina Muckenthaler, 219479

Opening Ceremony: Chair

EHA Library, Martina Muckenthaler, 219114

Award ceremony

EHA Library, Ruud Delwel, 219115

Award ceremony: Education and mentoring awards

EHA Library, Pieter Sonneveld, 219480

Opening Ceremony: Chair

EHA Library, Pieter Sonneveld, 219113

CC-122, A NOVEL CEREBLON-MODULATING AGENT, IN COMBINATION WITH OBINUTUZUMAB (GA101) IN PATIENTS WITH RELAPSED AND REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Jean-Marie Michot, 214437

A NOVEL ΒETA1-TUBULIN-BASED MEGAKARYOCYTE REPORTER SYSTEM IDENTIFIES COMPOUNDS THAT PROMOTE MEGAKARYOCYTE MATURATION AND PLATELET PRODUCTION

EHA Library, Si Jing Chen, 214600

RESURRECTING RESPONSE TO RUXOLITINIB: A PHASE I STUDY TESTING THE COMBINATION OF RUXOLITINIB AND THE PI3K DELTA INHIBITOR UMBRALISIB IN RUXOLITINIB-EXPERIENCED MYELOFIBROSIS

EHA Library, Tamara Moyo, 214514

UPDATED EFFICACY AND MRD DATA ACCORDING TO RISK-STATUS IN NEWLY DIAGNOSED MYELOMA PATIENTS TREATED WITH CARFILZOMIB PLUS LENALIDOMIDE OR CYCLOPHOSPHAMIDE: RESULTS FROM THE FORTE TRIAL

EHA Library, Francesca Gay, 214503

FATIGUE AT BASELINE IS ASSOCIATED WITH GERIATRIC IMPAIRMENTS AND PREDICTS SHORTER SURVIVAL IN OLDER PATIENTS WITH A HEMATOLOGICAL MALIGNANCY

EHA Library, Reinhard Stauder, 214520

RELAPSED AML IN CHILDREN: IMPROVED OUTCOME

EHA Library, Mareike Rasche, 214441

REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR DIFFUSE LARGE B-CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO-IDENTICAL VS. FULLY MATCHED RELATED DONORS. A CIBMTR & EBMT ANALYSIS

EHA Library, Peter Dreger, 214512

CHECKMATE 205 COHORT D: A PHASE 2 TRIAL OF NIVOLUMAB FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA

EHA Library, Radhakrishnan Ramchandren, 214507

BB2121 ANTI-BCMA CAR T CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS FROM A MULTICENTER PHASE I STUDY

EHA Library, Jesus Berdeja, 214444

STAG2 REGULATES HEMATOPOIETIC DIFFERENTIATION AND SELF-RENEWAL

EHA Library, Yotaro Ochi, 214509

IMPROVEMENTS IN CARDIAC BIOMARKERS ARE ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS

EHA Library, Tiffany Quock, 214447

ABNORMAL BLEEDING ASSOCIATED WITH COAGULATION ABNORMALITIES IN SYSTEMIC AMYLOIDOSIS

EHA Library, Kai Sun, 214519

BRENTUXIMAB VEDOTIN + ESHAP (BRESHAP) FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT: HIGH COMPLETE REMISSION RATE AND LONG-TERM TIME TO TREATMENT FAILURE IN REFRACTORY/RELAPSED HODGKIN LYMPHOMA.

EHA Library, Ramon Garcia-Sanz, 214506

COMPARISON OF LONG-TERM EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B VS. HU IN POLYCYTHEMIA VERA PATIENTS AGED BELOW OR ABOVE 60 YEARS: TWO-YEAR ANALYSIS FROM THE PROUD/CONTINUATION PHASE III TRIALS

EHA Library, Heinz Gisslinger, 214443

TRENDS IN THE USE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE MANAGEMENT OF RELAPSED/REFRACTORY HODGKIN LYMPHOMA. A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY OF THE EBMT

EHA Library, Anna Sureda, 214442

RESULTS OF A PHASE 1B/2 STUDY OF ENTOSPLETINIB (GS-9973) MONOTHERAPY AND IN COMBINATION WITH INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Alison Walker, 214440

ALTERED COHESIN ACTIVITY AT DIFFERENTIATION-SPECIFIC ACTIVE CIS-REGULATORY ELEMENTS PREDICTS THE FATE OF COHESIN-PERTURBED HAEMATOPOIESIS

EHA Library, Daniel Sasca, 214595

LEUKEMIA CELL-DERIVED MICROVESICLES INDUCE T CELL EXHAUSTION VIA MIRNA DELIVERY

EHA Library, Jieke Cui, 214598

CONSOLIDATION FOLLOWED BY MAINTENANCE VS MAINTENANCE ALONE IN NEWLY DIAGNOSED, TRANSPLANT ELIGIBLE MULTIPLE MYELOMA: A RANDOMIZED PHASE 3 STUDY OF THE EUROPEAN MYELOMA NETWORK (EMN02/HO95 MM TRIAL)

EHA Library, Pieter Sonneveld, 214488

TP53 MUTATIONS, BUT NOT NOTCH2 OR KLF2 MUTATIONS, IDENTIFY PATIENTS WITH POOR PROGNOSIS IN SPLENIC MARGINAL ZONE LYMPHOMA – INTERIM ANALYSIS OF THE IELSG46 STUDY

EHA Library, Francesca Guidetti, 214485

BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN HIGH RISK ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA (CHL) PATIENTS: RESULTS OF PRE-SPECIFIED SUB-GROUP ANALYSES FROM THE ECHELON-1 STUDY

EHA Library, Martin Hutchings, 214505

P53 ISOFORM D133P53A: A NEW TRANSCRIPTIONAL ENHANCER OF T-CELL EFFECTOR FUNCTION

EHA Library, Kevin Legscha, 214516

LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB IN 248 ADULT IMMUNE THROMBOCYTOPENIA PATIENTS: RESULTS WITH MORE THAN 5 YEARS OF FOLLOW-UP FROM A FRENCH PROSPECTIVE REGISTRY ITP-RITUX

EHA Library, Samuel DESHAYES, 214518

THE IMPACT OF RECIPIENT AGE ON ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOME –A COMPARISON BETWEEN SIBLINGS VERSUS UNRELATED VERSUS ALTERNATIVE DONORS: AN ANALYSIS ON BEHALF OF THE ALWP OF THE EBMT

EHA Library, Roni Shouval, 214596

INTERIM ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN MPN PATIENTS.

EHA Library, Trine Alma Knudsen, 214492

LONG TERM SURVIVAL OF PATIENTS WITH EVANS SYNDROME: A POPULATION-BASED COHORT STUDY

EHA Library, Dennis Lund Hansen, 214601

A RANDOMISED EVALUATION OF LOW-DOSE ARA-C PLUS TOSEDOSTAT VERSUS LOW DOSE ARA-C IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS OF THE LI-1 TRIAL

EHA Library, Mike Dennis, 214439

TWO YEARS RITUXIMAB MAINTENANCE VS. OBSERVATION AFTER FIRST LINE TREATMENT WITH BENDAMUSTINE PLUS RITUXIMAB IN PATIENTS WITH MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF THE STIL NHL7-2008 MAINTAIN TRIAL

EHA Library, Mathias Rummel, 214436

DARATUMUMAB PLUS BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) IN ELDERLY (≥75 YEARS OF AGE) PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INELIGIBLE FOR TRANSPLANTATION (ALCYONE)

EHA Library, Jesús San Miguel, 214502

FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: PRELIMINARY RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY

EHA Library, David J Kuter, 214446

AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND EFFECTIVE FOR OLDER MYELOMA PATIENTS: RESULTS FROM THE MYELOMA XI TRIAL

EHA Library, Charlotte Pawlyn, 214501

THE ROLE OF MINIMAL RESIDUAL DISEASE AT THE TIME OF TRANSPLANTATION IN PATIENTS WITH AML IN CR2 AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. A STUDY OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.

EHA Library, Arnon Nagler, 214511

FREQUENT IMMUNOGLOBULIN REARRANGEMENT, JAK1/2 INHIBITION AND AGGRESSIVE B-CELL LYMPHOMA DEVELOPMENT IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Veronika Sexl, 214513

PRETREATMENT VITAMIN D DEFICIENCY IS ASSOCIATED WITH LOWER PROGRESSION-FREE AND OVERALL SURVIVAL IN PROSPECTIVELY TREATED HODGKIN LYMPHOMA

EHA Library, Sven Borchmann, 214592

PHARMACOLOGIC DISPLACEMENT OF LSD1 FROM GFI1 ACTIVATES PRIMED ENHANCERS TO INDUCE DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Maiques Diaz, 214508

RESULTS OF PIVOTAL PHASE 2 TRIAL OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Naveen Pemmaraju, 214438

CLINICAL-GRADE PRODUCTION, PRECLINICAL EFFICACY AND SAFETY OF ALLOGENEIC CD19CAR CYTOKINE-INDUCED KILLER CELLS TRANSFECTED WITH SLEEPING BEAUTY TRANSPOSON FOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT

EHA Library, Chiara F Magnani, 214515

FACTORS INFLUENCING MANAGEMENT OF ANTIPLATELET DRUGS IN THROMBOCYTOPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCY

EHA Library, Avi Leader, 214517

PATIENTS WITH HIGH RISK FEATURES ACCORDING TO PRIMA PI HAVE SIGNIFICANTLY HIGHER RISK TO DIE EVEN IF THEY ARE LATE PROGRESSORS.

EHA Library, Marek Trneny, 214435

COMPARISON OF STANDARD- AND LOW-DOSE RITUXIMAB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): DATA FROM THE UK ITP REGISTRY

EHA Library, Caitlin Gracie, 214599

COMPARATIVE PERFORMANCE OF PROGNOSTIC SYSTEMS IN PATIENTS WITH MYELOFIBROSIS SECONDARY TO PV AND ET AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION

EHA Library, Nico Gagelmann, 214597

PROGNOSTIC AND BIOLOGIC SIGNIFICANCE OF CIRCULAR RNA PROFILING IN YOUNGER ADULT PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML)

EHA Library, Dimitrios PAPAIOANNOU, 214594

VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE THERAPY IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL

EHA Library, Laura Cicconi, 214593

FINAL ANALYSIS OF THE AHL2011 RANDOMIZED PHASE III LYSA STUDY COMPARING AN EARLY PET DRIVEN TREATMENT DE-ESCALATION TO A NOT PET-MONITORED STRATEGY IN PATIENTS WITH ADVANCED STAGES HODGKIN LYMPHOMA

EHA Library, Olivier CASASNOVAS, 214504

PRE-CLINICAL RESULTS OF A HUMANIZED CART-BCMA FOR MULTIPLE MYELOMA PATIENTS

EHA Library, Lorena Pérez Amill, 214493

INTERIM UPDATE FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

EHA Library, Gilles Salles, 214434

Blood transfusion in patients with sickle cell disease

EHA Library, Karina Yazdanbakhsh, 219112

BUSULFAN + MELPHALAN WAS ASSOCIATED WITH A LONGER PFS COMPARED TO MELPHALAN ALONE IN HIGH-RISK MULTIPLE MYELOMA IN A RANDOMIZED PHASE 3 CLINICAL TRIAL

EHA Library, Muzaffar H. Qazilbash, 214510

A TRIPLET BORTEZOMIB- AND IMMUNOMODULATOR-BASED THERAPY BEFORE AND AFTER DOUBLE ASCT IMPROVES OVERALL SURVIVAL OF NEWLY DIAGNOSED MM PATIENTS: FINAL ANALYSIS OF PHASE 3 GIMEMA-MMY-3006 STUDY

EHA Library, Paola Tacchetti, 214500

A ROLE OF PIEZO1 IN ERYTHROID DIFFERENTIATION OF NORMAL AND HEREDITARY XEROCYTOSIS DERIVED HEMATOPOIETIC PROGENITORS.

EHA Library, Alexis Caulier, 214445

Evolving gene therapy for primary immunodeficiency

EHA Library, Adrian Thrasher, 219099

Morphology of multiple myeloma, a patchy disease

EHA Library, Gina Zini, 219101

Flow cytometry for Minimal/Measurable Residual Disease Detection (MRD) in Chronic Lymphocytic Leukaemia (CLL)

EHA Library, Andy Rawstron, 219103

Introduction: Technical innovations in MRD measurements

EHA Library, Jaques J. M. van Dongen, 219105

Droplet digital (dd) PCR for improved MRD measurements

EHA Library, Daniela Drandi, 219106

Flowcytometric analysis of minimal residual disease in multiple myeloma

EHA Library, Vincent Velden, van der, 219102

Update on congenital neutropenia

EHA Library, Karl Welte, 219098

Immune development during fetal life and beyond, in health and disease

EHA Library, Raz Somech, 219097